CAPR News

Class Action Lawsuit Alert: Levi & Korsinsky Reminds Capricor Therapeutics, Inc. (CAPR) Investors of September 28, 2026 Deadline

Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Capricor Therapeutics, Inc. (CAPR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

CAPR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

CAPR LAWSUIT ALERT: Levi & Korsinsky Notifies Capricor Therapeutics, Inc. Investors - Lead Plaintiff Deadline September 28, 2026

Capricor (CAPR) Securities Investigation Notice - Levi & Korsinsky

Levi & Korsinsky Reminds Capricor Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026 - CAPR

CAPR INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Capricor Therapeutics, Inc. (CAPR) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before September 28, 2026

CAPR Legal News: Capricor Therapeutics Hit with Securities Fraud Class Action over Alleged Misrepresentations about its Clinical Data – Contact BFA Law